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Bonnie Bruce and colleagues [1] report on the develop-
ment process of the PROMIS item data bank. In their 
article the authors describe the stepwise process by 
which they systematically searched for items reﬂ  ecting 
physical function, and then reﬁ   ned and evaluated a 
subset of these items for further application in the 
functional assessment of patients with rheumatic diseases 
by new instruments or by computerised adaptive testing 
(CAT).
Many patient reported outcomes that focus on 
functional capacity have been published for use in rheu-
matic diseases, and rheumatoid arthritis (RA) usually 
serves as a paradigmatic example of such chronic disease 
[2]. Physical function has always been a core outcome in 
RA, even surpassing more ‘objective’ outcomes, such as 
radiographically observed damage. Th   e measurement of 
physical function has been revolutionised by the 
development of the Health Assessment Questionnaire 
(HAQ) Disability Index (HAQ-DI), which was introduced 
by Fries and colleagues in the early 1980s [3]. Th  e  original 
HAQ or its modiﬁ  cations are by now the most commonly 
used functional measures reported in the various clinical 
databases and in clinical trials of RA. However, they 
might not be appropriate for all patients.
In their current report, Bruce and colleagues [1] 
elegantly show that attempts to improve functional 
assessment must start at the level of the individual items 
that an outcome measure will eventually be composed of. 
Th   ey conclude that items work better if their wording is 
in the present tense rather than the past tense, if they 
focus on the ability to do activities rather than actual 
performance, if they are simple, and if they have four to 
ﬁ  ve response options rather than only two to three.
Th  e most promising application of such items is in 
CAT. For this purpose, items that are well calibrated on a 
respective metric (for example, physical function) are 
needed. Th   e great advantage of CAT in medical 
assessment in general, and functional assessment in 
rheumatic disease in particular, is its ability to provide 
uniformly precise scores for most patients [4].  Th  e 
computer usually selects a starting item (question) that is 
of average diﬃ   culty. Based on the patient’s response, the 
computer will update its estimation of, for example, the 
patient’s functional ability and accordingly select an 
easier or harder question. Th  is will be repeated until 
some level of precision is achieved (for example, by the 
width of the standard deviation of the estimate or 
similar), that is, when a termination criterion is reached. 
Th   is is a major advantage over standard ﬁ  xed tests, such 
as the HAQ, which are usually most precise for patients 
of average functional capacity, and decreasingly less 
precise for those with more extreme test scores. Th  us, 
CAT can diminish the ﬂ  oor and ceiling eﬀ  ects seen in 
standard instruments, as the authors also discuss.
Is this relevant for functional assessments in RA? Yes, 
in terms of the expected trajectories of the patients’ 
disease activity and function; in other words, patients 
with RA experience great changes in disease activity and 
function given the new treatment strategies and new and 
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© 2010 BioMed Central Ltdeﬀ   ective drug regimens [5]. Th  ey are more than ever 
prone to make transitions across large ranges of the latent 
metric of functional capacity. Patients and investigators/
rheumatologists will therefore beneﬁ  t from instruments 
that provide comparably precise estimates at the 
beginning of therapy and during follow-up.
Likewise, it will also be relevant regarding several 
aspects of physical function that have enjoyed much less 
attention in the past. Th  ese include the question of 
reversibility of functional limitations - that is, the highly 
pertinent question of ‘What is the best possible func-
tional capacity in an individual patient?’ - as well as the 
recently estimated translation of joint damage (by radio-
graphic evaluation) to functional disability [6]. More 
precise measures will also allow even more accurate 
functional outcomes research.
Will it work in the respective relevant age group of the 
middle-aged to the elderly? Yes, probably also in terms of 
the ability of the elderly population to follow and perform 
a computer test, especially when they receive a training 
session in advance [7]. Even to the contrary, elderly 
patients in particular are often overwhelmed with the 
increasing number of surveys and questionnaires, and an 
assessment approach that employs CAT will save their 
time and energy by providing similar or better precision 
with fewer test items. As the authors say, with regard to 
educational testing this aspect of CAT is especially 
important.
Th  e downsides of CAT are the considerably higher 
costs of testing and calibrating the items in large numbers 
of patients. Th   is has already been partly achieved in the 
present study, even if there is still a need to expand it to a 
wider range of rheumatic diseases. However, some 
remaining issues will need to be addressed, including the 
fact that numerous new tools can now be developed by 
individual researchers who wish to conduct a speciﬁ  c 
study [8]. It still needs to be communicated how we can 
interpret ‘custom-made’ adaptive functional scales with, 
for example, traditional HAQ scores as we know them. 
As the literature is ﬁ  lled with scores of standard HAQ or 
SF-36 surveys, it might be wise to encourage investigators 
to collect data on the traditional tools in addition to the 
new scales. Th  is will facilitate the interpretation of the 
results. It is likely, however, that the CAT results will not 
be very diﬀ  erent from traditional functional scales, but 
that their standard deviations will be smaller. Th  is is 
relevant, as functional outcomes - and patient reported 
outcomes in general - will be increasingly used as 
endpoints in clinical trials. Th  e increased statistical 
power of CAT analyses will decrease sample size 
requirements for studies, and accordingly, smaller 
number of patients will be put on placebo (or comparator 
therapy). Finally, such studies will be much less costly.
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